Comment
doi: 10.1136/bmjebm-2018-110899.
Epub 2018 Apr 12.
Rivaroxaban plus aspirin, compared with aspirin alone, reduced cardiovascular events in patients with stable peripheral or carotid artery disease, but increased the risk of major bleeding
Affiliations
- PMID: 29650723
- DOI: 10.1136/bmjebm-2018-110899
Item in Clipboard
Comment
Rivaroxaban plus aspirin, compared with aspirin alone, reduced cardiovascular events in patients with stable peripheral or carotid artery disease, but increased the risk of major bleeding
BMJ Evid Based Med.
2018 Oct.
No abstract available
Keywords: coronary heart disease; preventive medicine; primary care; stroke; vascular medicine.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10. Lancet. 2018. PMID: 29132880 Clinical Trial.
Similar articles
-
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10. Lancet. 2018. PMID: 29132880 Clinical Trial.
-
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.Lancet. 2018 Jan 20;391(10117):205-218. doi: 10.1016/S0140-6736(17)32458-3. Epub 2017 Nov 10. Lancet. 2018. PMID: 29132879 Clinical Trial.
-
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective.Eur J Prev Cardiol. 2019 May;26(8):858-868. doi: 10.1177/2047487318817910. Epub 2018 Dec 10. Eur J Prev Cardiol. 2019. PMID: 30526023
-
Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease.Curr Med Res Opin. 2022 Jan;38(1):27-34. doi: 10.1080/03007995.2021.1991294. Epub 2021 Oct 26. Curr Med Res Opin. 2022. PMID: 34641745
-
Comparison of Aspirin and Rivaroxaban Plus Aspirin in the Management of Stable Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomized Controlled Trials.Int J Gen Med. 2022 Sep 12;15:7201-7208. doi: 10.2147/IJGM.S383485. eCollection 2022. Int J Gen Med. 2022. PMID: 36118183 Free PMC article. Review.
Cited by
-
The Association Between Peripheral Arterial Disease and Long-Term Bleeding Events in Patients with Acute Myocardial Infarction.J Clin Med. 2025 May 4;14(9):3183. doi: 10.3390/jcm14093183. J Clin Med. 2025. PMID: 40364214 Free PMC article.
-
Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis.Am J Cardiovasc Drugs. 2023 May;23(3):257-267. doi: 10.1007/s40256-023-00574-9. Epub 2023 Mar 3. Am J Cardiovasc Drugs. 2023. PMID: 36867384
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
